Literature DB >> 9213096

The regulation of gene expression in hypertrophying skeletal muscle.

J A Carson1.   

Abstract

Mesh：

Year:  1997        PMID： 9213096

Source DB:  PubMed          Journal:  Exerc Sport Sci Rev        ISSN： 0091-6331            Impact factor:   6.230


× No keyword cloud information.
  7 in total

Review 1.  The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting.

Authors:  James A Carson; Justin P Hardee; Brandon N VanderVeen
Journal:  Semin Cell Dev Biol       Date:  2015-12-01       Impact factor: 7.727

Review 2.  The Impact of Immune Cells on the Skeletal Muscle Microenvironment During Cancer Cachexia.

Authors:  Brandon N VanderVeen; E Angela Murphy; James A Carson
Journal:  Front Physiol       Date:  2020-08-31       Impact factor: 4.566

Review 3.  The role of resistance exercise intensity on muscle fibre adaptations.

Authors:  Andrew C Fry
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

4.  The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy.

Authors:  Julie Lagirand-Cantaloube; Nicolas Offner; Alfredo Csibi; Marie P Leibovitch; Sabrina Batonnet-Pichon; Lionel A Tintignac; Carlos T Segura; Serge A Leibovitch
Journal:  EMBO J       Date:  2008-03-20       Impact factor: 11.598

Review 5.  Resistance Exercise's Ability to Reverse Cancer-Induced Anabolic Resistance.

Authors:  Ryan N Montalvo; Justin P Hardee; Brandon N VanderVeen; James A Carson
Journal:  Exerc Sport Sci Rev       Date:  2018-10       Impact factor: 6.230

6.  Human muscle gene expression following resistance exercise and blood flow restriction.

Authors:  Micah J Drummond; Satoshi Fujita; Takashi Abe; Abe Takashi; Hans C Dreyer; Elena Volpi; Blake B Rasmussen
Journal:  Med Sci Sports Exerc       Date:  2008-04       Impact factor: 5.411

Review 7.  The translational factor eIF3f: the ambivalent eIF3 subunit.

Authors:  Roberta Marchione; Serge A Leibovitch; Jean-Luc Lenormand
Journal:  Cell Mol Life Sci       Date:  2013-01-25       Impact factor: 9.261
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.